chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had knot on right mandible mobile that came up 24-48 hours after shot it was tender.  At 72 hours no longer tender but large >2cm.
sore arm - three days fatigue - two days so far strange wooziness - two days so far
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021 at 3:47 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 30-Nov-2021 at 3:47 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial undergone temperature excursions for 1 month. The vial was in frozen state at the time of the excursion and stored in a super cold Freezer. The patient was given dose from vial that was stored in an ultracold freezer which was colder than it should have been. On 19-Nov-2021, the vial moved from freezer to refrigerator, the day when Moderna Covid-19 vials went from the super cold freezer to the refrigerator.  No treatment medications were reported.
Patient immediately had a syncope episode after injection. Patient tensed up and made grunting sounds. Episode lasted 10-15 seconds. EMS was called and assessed patient. Patient refused further medical services.
c/o h/a w/in 1 hrs of immun; temp ck'd @ home; t99.5 oral few hrs later began vomiting; vomited about 2 hrs; temp @ home 104.5 oral had given APAP but pt vomited; carried to ER;
Shortness of  breath 11/9 during exercise. Left side ribcage tender 11/10 early day and continued to worsen till my wife drove me to the ER locally early a.m. 11/11. A day of testing and diagnosis is Pulmonary Embolism lower left lung and DVT left outer calf.
Had several myclonic seizures during the morning which ended in a grand mal seizure later in the morning of March 25th which resulted in my shoulder being shattered. This led to me having a reverse shoulder replacement.
**swollen lymph node in armpit**, severe body aches, chills, sweats, low grade fever, sore arm & rash near injection sight
A little fever; This is a spontaneous report from a contactable consumer (patient). A 23-years-old male patient received second dose of bnt162b2 (Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration in left arm on 19Jul2021 13:45 (at age of 23-years-old) as dose 2, single for covid-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (Formulation: Solution for injection, Lot number: Unknown) via an unspecified route of administration in left arm on 28Jun2021 11:00 as dose 1, single dose for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medication within 2 weeks of vaccination. Prior to vaccination and since the vaccination, the patient was not diagnosed with COVID-19. On 21Jul2021 at 11:30, the patient experienced a little fever. Therapeutic measures were taken as a result of a little fever (pyrexia). The outcome of event was recovered.  Information on batch number has been requested.
Second dose of Pfizer vaccine was given on 1/8/21 and on 3/8/21 I noticed a hypopigmented circular  area approximately 1.25 inches in diameter on my left arm where the vaccine was given.   It has a slight tenderness/parasthesia to the touch.   It has been winter time so I have been wearing long sleeves when outdoors and have not had that area exposed to sun any more or less than the rest of the left arm.  Also, after second dose did not even have a bandaid applied in Jan.
Ever since administration of injection, I have had a severe pain to left upper arm at and around injection site. Arm pain worsens with movement of arm especially when trying to lift items or open/close doors. Heat has been applied and ibuprofen has been taken around the clock. Arm continues to hurt despite use of the these treatments. PCP made aware and recommended these treatments that are already being used, also recommended that I could go to urgent care.  Unsure whether to go to urgent care or what to do from here.
headache (16 hours) muscle ache (36 hours) chills (18 hours)
hot flashes; palpitations; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PALPITATIONS (palpitations) and HOT FLUSH (hot flashes) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039KorR0A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa), Drug allergy (TRAZADONE), Food allergy (GLUTEN & DAIRY SENSITIVE) and Allergy to animal (CATS). Concomitant products included CALCIUM for Osteopenia, VITAMIN D [VITAMIN D NOS], VITAMIN E [VITAMIN E NOS], MULTIVITAMIN [VITAMINS NOS] and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Dec-2020, the patient experienced PALPITATIONS (palpitations). On an unknown date, the patient experienced HOT FLUSH (hot flashes). At the time of the report, PALPITATIONS (palpitations) and HOT FLUSH (hot flashes) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test negative: negative (Negative) Covid-19 test-Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient had post menopausal for over 17 years.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Moderna ADR form
Patient has persistent redness and itching at the vaccine site that was present beginning the day after vaccination, went away initially and has now returned and has been present for roughly a week
I checked my blood pressure and it was 190/104; my vision was off, reading bothered; horrendous headache/had this tremendous headache and banger of a headache; This is a spontaneous report from a non-contactable Nurse (patient self, reported). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 04Feb2021, as a single dose for COVID-19 immunization. The patient's medical history included high blood pressure (that was controlled with medication). Concomitant medications were not reported. The patient reported that she had 1st dose of the Pfizer vaccine on Thursday, On 05Feb2021, Friday morning she started with, woke up with horrendous headache, took Motrin, didn't touch it, had it all afternoon, her vision was off, reading bothered. She checked her blood pressure, and it was 190/104. That was why she had this tremendous headache and banger of a headache. Because of her background, she knew what to do. She took her medications early and took additional medications that she knew was safe, and within an hour and a half the headache started to subside, she has been fine since. She was concerned about the second dose and would like some information and because of her adverse reaction, she was hesitant to get the second vaccine. Outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
itch all over body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itch all over body) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PRURITUS (itch all over body). At the time of the report, PRURITUS (itch all over body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
1st shot in 2018, 2nd shot just now in 2022; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix vaccine (1st dose received in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.       Additional Information: GSK Receipt Date: 07-SEP-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter reported that the patient received second dose of Shingrix vaccine in 2022. The reporter stated that the patient thought to get a second dose because the pharmacist said that the time between shots was good . Patient stated but your site said 3 to 6 months apart. Follow-up would not possible as no contact details were available. Additional supportive information: The patient received 2nd dose of Shingrix late than recommended time frame, which led to which led to lengthening of interval between vaccine doses.
allergic reaction; swelling and numbness to her mouth, lips, and tongue; swelling and numbness to her mouth, lips, and tongue; swelling and numbness to her mouth, lips, and tongue; swelling and numbness to her mouth, lips, and tongue; face was numb and heavy; face was numb and heavy; This is a spontaneous report from a contactable consumer (patient herself). A 47-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, NDC number: 59267100002), via an unspecified route of administration, administered in the left arm on 09Mar2021 at 15:00 at the age of 47 years old (Batch/Lot number: FN6198/EN6198, and Expiration date: unknown) as the 1st dose, single dose for COVID-19 immunization, to protect herself from getting COVID-19. The patient had no medical history. There were no concomitant medications. The patient reportedly experienced swelling and numbness to her mouth, lips, and tongue on an unspecified date in Mar2021. The patient was asking if there was any research to determine what she might have reacted to in the vaccine and also if there was any information about the kind of reaction she had and if that would relate to a specific ingredient. It was further reported that the patient had an allergic reaction to the first dose of the COVID vaccine and did not provide specifics. The patient wanted to know if there were studies on allergic reactions and if there had been any follow ups and would love to know what she was allergic to, since she had never had an anaphylactic reaction and if there had been any research. The patient stated she was seen at the emergency room and did not know if she should share the doctor's information that had seen her in the emergency room or her primary care doctor. She had mouth, tongue, lip swelling and numbness and so she went right away to the emergency room. She never had breathing distress and was given an intravenous (IV) steroid and also a medication to bring down the swelling. The patient stated she had the vaccine around 3pm in the afternoon and she woke up around 3am during the night on an unspecified date in Mar2021 and her face was numb and heavy and her lips were huge and she realized she was breathing ok, but she went to the emergency room. The patient stated she wanted to get the second dose of the vaccine, but the emergency room doctor did not recommend it. She clarified that the symptom of her mouth tongue lip swelling and numbness had actually occurred sometime in Mar2021, and not Feb2021, since she got the vaccine on 09Mar2021. It lasted for about two days until it went down. The patient stated there had been no changes and she had not had anything different to eat. Therapeutic measures were taken as a result of all the events, which included IV steroid and a medication to bring down the swelling. The patient recovered from all the events on an unspecified date in Mar2021.
Patient woke up this morning with a local reaction to the arm which included swelling about the size of a half dollar, redness, itching, and soreness. Mom of patient gave her Loratidine and Acetaminophen.
Patient had an alergic reaction to the vaccine and his eyes were swollen .  The pharmacist suggested going to the doctors office and a couple of day later the patient was fine. He returned today to the pharmacy and everything was okey.
UrticariaPruritis Injection site pain, Injection site erythema, Injection site swelling
I have a sore throat with a mild cough. I also have a headache and body aches with extreme fatigue.
The patient was administered her first dose of the Pfizer Covid vaccine by our pharmacy intern. She was instructed to wait 15 minutes in the store before leaving. Towards the end of her observation period, a woman came to the pharmacy counter screaming and crying for help. We instructed someone to call 911, I grabbed an epi-pen, assessed the situation, and administered it into the patient in right thigh. She started to become alert and responsive. The patient described dizziness and tachycardia as her main symptoms. Once she was alert, we gave her water and observed her until the paramedics came.
numbing on the left side of face - eye, cheek, mouth and left fingers, thumb to pinky; numbing on the left side of face - eye, cheek, mouth and left fingers, thumb to pinky; numbing on the left side of face - eye, cheek, mouth and left fingers, thumb to pinky; numbing on the left side of face - eye, cheek, mouth and left fingers, thumb to pinky; This is a spontaneous report received from a contactable consumer (patient). A 58-year-old female patient received the first dose of BNT162B2 (lot number: ER8727), via unspecified route of administration in left arm on 26Mar2021 11:45 AM at single dose for COVID-19 immunisation. The patient's medical history included primary central nervous system lymphoma and seizure. The patient had allergies to tree nuts. The patient's concomitant medications included vitamins, fish oil. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient previously received levetiracetam (KEPPRA) (anti-seizure medication) that she had stopped in end of Jan2021. Approximately 21 hours after injection of vaccine, the patient experienced numbing on the left side of face - eye, cheek, mouth - and left fingers, thumb to pinky. Lasted about 10 minutes and feeling came back. Same thing happened 15 minutes later and then stopped. Events onset date reported as 27Mar2021 09:15 AM. The event resulted in doctor or other healthcare professional office/clinic visit. The patient contacted her oncologist, she resumed taking levetiracetam and will continue until 2 weeks after next shot (if decide to get it). The patient had routine brain MRI and all clear. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was unknown.   No follow-up attempts are needed. No further information is expected.
This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 60-year-old female patient who received Influenza vaccine for prophylaxis. Co-suspect products included Influenza vaccine for prophylaxis and Influenza vaccine for prophylaxis. The patient's past medical history included chickenpox (as a child, severe case). On an unknown date, the patient received Influenza vaccine at an unknown dose, Influenza vaccine at an unknown dose and Influenza vaccine at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine and not applicable after receiving Influenza vaccine and Influenza vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), influenza, vaccination failure (serious criteria GSK medically significant), influenza and fever. On an unknown date, the outcome of the vaccination failure and vaccination failure were unknown and the outcome of the influenza, influenza and fever were recovered/resolved. It was unknown if the reporter considered the vaccination failure, influenza, vaccination failure and influenza to be related to Influenza vaccine. It was unknown if the reporter considered the vaccination failure and influenza to be related to Influenza vaccine. It was unknown if the reporter considered the fever to be related to Influenza vaccine. Additional details were provided as follows: The age at vaccination was not reported. Twice in the past she got the flu after getting the flu vaccine and though the illness was shorter that it otherwise would have been because of the vaccine. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for influenza, time to onset for event and laboratory confirmation for influenza were not provided. The patient regularly gets the flu vaccine and usually has a low grade fever afterwards. The patient had denied permission to contact their physician. This case has been linked with the case US2018195484, reported by same reporter for same patient.
Information has been received from a registered nurse concerning someone who a patient knew of, who was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine (Wistar RA 27/3) and  then got mumps or measles. No further information was available because the person was not a patient of the office and the nurse had no other details. There was no product quality complaint. Additional information has been requested.
the other 2 were given somewhere else and can't confirm if they were intramuscular injections or not.; This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (the other 2 were given somewhere else and can't confirm if they were intramuscular injections or not.) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A, 037K20A and 041B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (the other 2 were given somewhere else and can't confirm if they were intramuscular injections or not.). On 23-Feb-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (the other 2 were given somewhere else and can't confirm if they were intramuscular injections or not.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.   This case was linked to MOD-2021-364970, MOD-2021-365086 (Patient Link).
Tongue is swollen; tongue is little swollen; Throat is swollen; This is a spontaneous report from a contactable consumer(patient). An unspecified age and gender patient received BNT162B2(Pfizer-Biontech Covid-19 Vaccine, Solution for injection, batch/lot number not provided), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced tongue is swollen; tongue is little swollen, Throat is swollen. Patient stated that I am having a problem. Concern: Consumer stated, my tongue is swollen, I took a shot my tongue is little swollen, what do I need to do, My tongue is swollen right now. When confirmed that the side effect came after taking Pfizer COVID 19 Vaccine, the reporter stated, "I don't know what it is, I just took the shot couple of days ago, the reporter called in about this and my tongue is swollen now, what do I need to, I am calling you and that's why I am calling, the patient had the COVID shot yes, and her throat was swollen. Patient was informed about the role of Pfizer Medical Information and offered the number. The Patient was suggested to visit Emergency room in case of emergency. The outcome of the events were unknown.  Information on the lot/batch number has been requested.
Patient's dose was drawn up wrong.  Nurse used 0.8ml of diluent rather than 1.8ml of diluent. As such, patient received stronger concentration of Pfizer dosing. Immediate notification of parent on consent done by MD completing this form.  Immediate notification of patient's primary care medical doctor/pediatrician as well who agrees no changes to management needed based on CDC protocols for administration of larger than typical dosing.
I had my vaccination 07/11/2022. On 11/28/2022 I started to have extreme fatigue sinus congestion and low grade fever of 100 degrees. I tested COVID-19 negative on 11/29/2022. I went to urgent care on 11/30/2022 and I tested COVID-19 positive. I was prescribed a cough medicine and PAXLOVID. I stopped after the first 2 doses due to the horrible taste from the medication. I was very sick for 2 weeks. The 3rd and 4th week was full of congestion. I still have continuous post nasal drip on 01/10/2023.